Related by context. All words. (Click for frequent words.) 75 elotuzumab 74 JAK inhibitor 73 Ocrelizumab 72 midstage clinical 72 Canvaxin 71 lumiliximab 71 phase IIb 71 Nuvion 71 Nexavar sorafenib 71 iniparib 70 baminercept 70 Phenoptin 70 phase IIb clinical 70 motesanib 70 pertuzumab 70 figitumumab 70 atacicept 70 tremelimumab 70 PRT# 70 HuLuc# 70 Aflibercept 70 Arranon 70 daclizumab 70 volociximab 69 Bicifadine 69 fostamatinib 69 aleglitazar 69 alvespimycin 69 dacetuzumab 69 Asentar 69 pradefovir 69 vandetanib 69 phase IIa 69 axitinib 69 dirucotide 69 Dacogen injection 69 midstage trials 69 Cinquil 69 Arcalyst 69 valopicitabine 69 Desmoteplase 69 evaluating tivozanib 69 Telintra 69 HuMax EGFr 69 oral prodrug 69 HuMax CD4 69 rNAPc2 69 Plicera 69 phase IIa clinical 69 Viramidine 69 Corlux 69 BAY #-# 69 Phase IIb trials 69 virus HCV protease inhibitor 68 VEGF Trap 68 aflibercept 68 TACI Ig 68 custirsen 68 teriflunomide 68 taranabant 68 Amigal 68 riociguat 68 Adentri 68 severe hypercholesterolemia 68 Fibrillex TM 68 PF # [002] 68 pomalidomide 68 methylnaltrexone 68 eltrombopag 68 faropenem 68 dimebon 68 MAGE A3 ASCI 68 darapladib 68 INCB# [001] 68 AEGR 68 BRAF inhibitor 68 refractory gout 68 TELINTRA 68 lomitapide 68 LAF# 68 Phase Ib clinical 68 cabazitaxel 68 tanespimycin 68 velafermin 68 PEG SN# 68 GSK# [002] 68 Targretin 68 ganetespib 68 ACTEMRA TM 68 Archexin 68 ELND# 67 panitumumab Vectibix 67 PEG Interferon lambda 67 Zalbin 67 HuMax CD# 67 SinuNase 67 proteasome inhibitor 67 regorafenib 67 visilizumab 67 SAR# [004] 67 otelixizumab 67 docetaxel Taxotere R 67 ASA# 67 Rebif ® 67 Relovair 67 tanezumab 67 mipomersen 67 Lu AA# 67 GALNS 67 ProSavin 67 Mipomersen 67 Phase IIIb clinical 67 cannabinor 67 Dasatinib 67 PEG PAL 67 clazosentan 67 bicifadine 67 Bezielle 67 RhuDex ® 67 Revlimid lenalidomide 67 Zerenex 67 rilonacept 67 mertansine 67 Daclizumab 67 Vitaxin 67 zalutumumab 67 bendamustine 67 Fablyn 67 atrasentan 67 Telcyta 66 vidofludimus 66 Velcade bortezomib 66 forodesine 66 zanolimumab 66 Aplidin 66 GSK# [001] 66 phase IIb trial 66 Herceptin trastuzumab 66 Genentech Rituxan 66 Tarceva TM 66 Laquinimod 66 Pimavanserin 66 terlipressin 66 deforolimus 66 cathepsin K inhibitor 66 DU #b 66 HCD# [002] 66 anakinra 66 Ziopharm 66 Genentech Roche 66 Phase 2a trial 66 eprotirome 66 Torisel 66 PROMACTA 66 lapatinib Tykerb 66 tocilizumab 66 cediranib 66 IMA# 66 pegylated interferons 66 midstage studies 66 GW# [003] 66 Troxatyl 66 TBC# 66 CDP# 66 PXD# 66 experimental hepatitis C 66 ATL# [001] 66 Tarceva erlotinib 66 Removab 66 Pegintron 66 danoprevir 66 Allovectin 7 66 Factor VIIa 66 diarrhea predominant irritable 66 Ceflatonin 66 oral ridaforolimus 66 lixisenatide 66 sitaxsentan 66 HQK 66 Alzhemed TM 66 Aptivus ® 66 NV1FGF 66 brivaracetam 66 ularitide 66 erlotinib Tarceva 66 uric acid lowering 66 XmAb# 66 posaconazole 66 albinterferon alfa 2b 66 Syncria 66 iclaprim 66 Itopride 66 betrixaban 66 Phase #b/#a 65 antibody MAb 65 GVAX 65 dexpramipexole 65 oral cladribine 65 PDE4 inhibitor 65 Panzem R NCD 65 tasocitinib 65 cetuximab Erbitux 65 bardoxolone 65 Panzem R 65 RhuDex 65 enoximone 65 sargramostim 65 Xinlay 65 ridaforolimus 65 SPRYCEL ® 65 Starlix 65 Affinitak 65 nalbuphine ER 65 trastuzumab DM1 65 AVE# 65 ofatumumab 65 teplizumab 65 RITUXAN 65 decitabine 65 Theratope 65 romiplostim 65 Ramoplanin 65 Reverset 65 Diamyd ® 65 AVASTIN 65 JAK inhibitors 65 HGS ETR1 65 obatoclax 65 Onconase 65 MNTX 65 Phase #/#a 65 Phase IIa clinical 65 cilengitide 65 reslizumab 65 apremilast 65 Atrasentan 65 ATL/TV# 65 TKM ApoB 65 Phase IIa trials 65 phase IIb study 65 Phase Ib 65 senicapoc 65 TELCYTA 65 PEG INTRON 65 Fx #A 65 IL# PE#QQR 65 Xelox 65 romidepsin 65 Insegia 65 Gleevec imatinib mesylate 65 Ixempra 65 CIMZIA TM 65 Pirfenidone 65 HGS# 65 PEGylated interferon beta 1a 65 PTK ZK 65 beta 1a 65 Vicriviroc 65 interferon gamma 1b 65 Firazyr 65 L BLP# 65 Tocosol Paclitaxel 65 HepeX B 65 Prestara 65 Phase IIb clinical trials 65 elesclomol 65 glatiramer 65 BIM #A# 65 gefitinib Iressa 65 muraglitazar 65 Cetrorelix 65 Vidaza azacitidine 65 celgosivir 65 Panzem 65 enzastaurin 65 LymphoStat B 65 oral methylnaltrexone 65 Cerovive 65 Phase Ib study 65 teduglutide 65 glufosfamide 65 Aurexis 65 almorexant 65 NP2 Enkephalin 65 rituximab Rituxan 65 Mylotarg 65 mapatumumab 65 LY# [003] 65 TroVax 65 Clolar ® 65 cancer neuroendocrine tumor 65 ponatinib 65 Triolex 65 cangrelor 65 arzoxifene 65 NVA# 64 FTY# 64 PD LID 64 thalidomide Thalomid 64 CEQ# 64 Gaboxadol 64 Neulasta ® 64 oxymorphone ER 64 diabetic neuropathic pain 64 receptor tyrosine kinase inhibitor 64 fingolimod 64 Prosaptide 64 investigational humanized monoclonal antibody 64 febuxostat 64 sunitinib malate 64 Epratuzumab 64 Unit Dose Budesonide 64 FOLOTYN ® 64 Regeneron Pharma 64 RSD# oral 64 antiplatelet agent 64 metaglidasen 64 drug figitumumab 64 QVA# 64 temsirolimus 64 Balaglitazone 64 canakinumab 64 Gattex 64 vismodegib 64 lesinurad 64 neratinib 64 Proxinium TM 64 UPLYSO 64 Phase 2a 64 Tolamba 64 phase Ib 64 MDV# 64 ACTIVE W 64 Golimumab 64 PREOS 64 Phase IIa trial 64 Hedgehog antagonist 64 Seattle Genetics SGEN 64 UVIDEM 64 huC# DM4 64 Taxotere ® 64 MAXY G# 64 ALKS 64 NSABP C 64 Rezular 64 AGILECT R 64 Noxafil 64 pazopanib 64 Bayer Onyx 64 recurrent glioblastoma multiforme 64 alvimopan 64 sorafenib Nexavar 64 Phase 1b trial 64 maribavir 64 Promacta 64 vemurafenib 64 Bifeprunox 64 Behcet uveitis 64 Boceprevir 64 eniluracil 64 midstage clinical trials 64 registrational trial 64 ZOLINZA 64 Rituxan rituximab 64 GLPG# 64 induced macular edema 64 Beyond Advair 64 Phase IIb clinical 64 sunitinib 64 Erbitux cetuximab 64 Peginterferon alfa 2b 64 Femara letrozole 64 heterozygous FH 64 omacetaxine mepesuccinate 64 afatinib 64 Sebivo 64 peginesatide 64 tesmilifene 64 Roche Pegasys 64 Alfimeprase 64 Benlysta belimumab 64 Phase 2b study 64 ISIS # 64 Sym# 64 bardoxolone methyl 64 Fodosine 64 Safinamide 64 angiogenesis inhibitor 64 Synavive 64 Tyrima 64 BCX# 64 Phase Ib clinical trials 64 Phase 2b clinical 64 CR# vcMMAE 64 Sprycel dasatinib 64 DPP4 inhibitor 64 R#/MEM 64 Jevtana 64 cetuximab Erbitux R 64 galiximab 64 alemtuzumab Campath 64 Amrubicin 64 R#/MEM # 64 Xanafide 64 Aryplase 64 MKC# MT 64 EndoTAG TM -1 64 Teriflunomide 64 Board DSMB 64 Muraglitazar 64 relapsed multiple myeloma 64 ruboxistaurin 64 BRIM3 64 ICA # 64 Phase III clinical 64 Genz # 64 bapineuzumab 64 Pazopanib 64 incyclinide 64 Pruvel 64 OHR/AVR# 64 Phase IIb trial 64 GRN# 64 mTOR inhibitor 64 elacytarabine 64 SinuNase TM 64 Pivotal Phase 64 BRIM2 64 LymphoStat B TM 64 solanezumab 64 squalamine 64 ACOMPLIA R 64 Raptiva ® 64 RAPTIVA R 64 canagliflozin 64 ULORIC 64 Oglemilast 64 Traficet EN 64 Clonicel 64 esophageal candidiasis 64 Annamycin 64 Actilon 64 daptomycin 64 TRO# 64 lixivaptan 64 Elocalcitol 64 KNS # 64 YONDELIS 64 vicriviroc 64 multicenter Phase 64 metastatic castration resistant 64 Zolinza 64 subcutaneous formulation 64 rolofylline 64 Dalbavancin 64 octreotide acetate 64 placebo controlled Phase 64 DEB# 64 fenretinide 64 Cimzia TM 64 tofacitinib 64 Lixivaptan 64 tolevamer 64 Actemra 64 docetaxel chemotherapy 64 LibiGel ® 64 Romiplostim 64 Dapagliflozin 64 ixabepilone 63 SUTENT ® 63 Quinamed 63 dextromethorphan quinidine 63 Nasulin 63 Vernakalant 63 Nexavar ® 63 dexanabinol 63 KRN# 63 Cancidas 63 Betaferon R 63 PegIntron 63 Sutent sunitinib 63 APTIVUS 63 pediatric acute lymphoblastic 63 GOUT 63 compound INCB# 63 MabThera rituximab 63 Stimuvax R 63 Campath ® 63 neurogenic orthostatic hypotension 63 IMC #B 63 CRD5 63 bortezomib Velcade 63 bosutinib 63 Initiate Phase 63 RELOVAIR ™ 63 Dacogen decitabine 63 TREANDA 63 Tavocept 63 talactoferrin 63 CBLC# 63 CCX# B 63 Fludara 63 MyVax personalized immunotherapy 63 investigational monoclonal antibody 63 class mGluR5 inhibitor 63 Vorapaxar 63 PRTX 63 refractory AML 63 DPX Survivac 63 OncoVex 63 tarenflurbil 63 APEX PD 63 MAXY alpha 63 Tykerb lapatinib 63 AEG# 63 glatiramer acetate 63 oral antiviral 63 safinamide 63 AVONEX ® 63 Allovectin 7 ® 63 glucokinase activator 63 refractory chronic lymphocytic 63 Zenvia ™ 63 acyclovir Lauriad R 63 fidaxomicin 63 urocortin 2 63 pafuramidine 63 olaparib 63 Immunogen 63 JAK3 inhibitor 63 MabThera Rituxan 63 Panitumumab 63 Cethrin 63 Phase 2b clinical trials 63 pan HDAC inhibitor 63 Phase IIa 63 Aurora kinase inhibitor 63 vosaroxin 63 Zoraxel 63 IPL# 63 telcagepant 63 selective androgen receptor modulator 63 Alemtuzumab 63 torezolid phosphate 63 Phase #b/#a trial 63 OvaRex 63 CIMZIA ™ 63 Avastin bevacizumab 63 linaclotide 63 edoxaban 63 Elotuzumab 63 SRT# [003] 63 sorafenib tablets 63 Rasagiline 63 Egrifta 63 motavizumab 63 relapsing remitting multiple sclerosis 63 Symadex 63 confirmatory Phase III 63 HMG CoA reductase inhibitors 63 Taxotere docetaxel 63 docetaxel Taxotere ® 63 alpha 2a 63 Tesmilifene 63 Pivotal Phase III 63 Xcytrin R 63 dimebon latrepirdine 63 retinal vein occlusion 63 Personalized Immunotherapy 63 orBec 63 MyVax 63 LymphoStat B belimumab 63 Enbrel etanercept 63 Glufosfamide 63 adecatumumab 63 Phase 2b Clinical Trial 63 SinuNase ™ 63 Pertuzumab 63 ISTODAX 63 midstage clinical trial 63 Leukine 63 epothilone 63 cobiprostone 63 Pegasys plus Copegus 63 xanthine oxidase inhibitor 63 TYZEKA 63 CA4P 63 multiple myeloma MM 63 Fibrillex 63 Folotyn 63 XL# XL# XL# XL# 63 tafamidis 63 Vandetanib 63 relapsed MM 63 ALN PCS 63 velaglucerase alfa 63 Certolizumab pegol 63 TORISEL 63 Avanafil 63 Viprinex 63 RhuDex TM 63 HCV SPRINT 63 Vaprisol 63 Factor Xa inhibitor 63 trastuzumab DM1 T DM1 63 AZILECT ® 63 olmesartan 63 tipranavir 63 tramiprosate Alzhemed TM 63 opioid induced bowel dysfunction 63 pharmacokinetic interactions 63 Onyx Pharma 63 ToGA 63 Myelodysplastic Syndrome MDS 63 ATACAND 63 elinogrel 63 Vertex telaprevir 63 LUCENTIS 63 Phase 1b 63 adecatumumab MT# 63 Actimmune ® 63 AERx iDMS 63 Allovectin 7 R 63 natalizumab 63 Neurodex 63 AstraZeneca Iressa 63 Horizant 63 entinostat 63 SNT MC# 63 HCV RESPOND 2 63 AZILECT R 63 antisense drug 63 sorafenib Nexavar R 63 Adalimumab 63 ORENCIA R 63 Santhera 63 subcutaneously administered 63 Tasigna nilotinib 63 cinacalcet HCl 63 pegaptanib 63 HGS ETR2 63 MEK inhibitor 63 TLK# 63 telbivudine 63 Riquent 63 mycophenolate mofetil 63 lintuzumab 63 CYT# potent vascular disrupting 63 6R BH4 63 Interferon beta 1b 63 THR beta agonist 63 Phase Ib II 63 Ridaforolimus 63 eosinophilic asthma 63 TOCOSOL Paclitaxel 63 ORAL Sync 63 darusentan 63 Campath 62 etanercept Enbrel 62 Tezampanel 62 Ostarine 62 RG# [001] 62 ZACTIMA 62 INTEGRILIN 62 cladribine 62 Cloretazine 62 GLP1 agonist 62 VEGF inhibitor 62 adalimumab Humira 62 Meets Primary Endpoint 62 alfimeprase 62 Mepact 62 Mycograb 62 ofatumumab HuMax CD# 62 R sorafenib tablets 62 GSK '# 62 ADAGIO study 62 EOquin 62 NGX# 62 Aliskiren 62 INCB# [003] 62 Azedra 62 investigational compound 62 tiapamil 62 TNF blocker therapy 62 antithrombotic 62 Solulin 62 liposomal formulation 62 Sorafenib 62 ulimorelin 62 EGS# 62 Darusentan 62 bifeprunox 62 RhuDex R 62 Amplimexon 62 Abiraterone acetate 62 JAK2 inhibitor 62 CytoFabTM 62 SILENOR 62 Icatibant 62 STRIDE PD 62 dyskinesia PD LID 62 Valdoxan 62 MIRCERA 62 ASONEP 62 Omacetaxine 62 Atacand 62 sunitinib Sutent 62 perifosine 62 Campath alemtuzumab 62 T DM1 62 Virulizin ® 62 Phase IIb 62 Votrient 62 Uvidem 62 Amevive 62 azacitidine 62 integrase inhibitor 62 Tyzeka 62 PEGylated Fab fragment 62 refractory CLL 62 Trastuzumab 62 Tysabri natalizumab 62 carfilzomib 62 Remicade infliximab 62 cariprazine 62 Dacogen 62 asenapine 62 phase 2a 62 Clolar 62 CD# monoclonal antibody 62 HBeAg negative patients 62 efalizumab 62 ganaxolone 62 OncoVEX GM CSF 62 refractory APL 62 Leukine ® 62 ImClone Erbitux 62 Eltrombopag 62 VEGF inhibitors 62 Certolizumab 62 randomized Phase IIb 62 Milnacipran 62 non nucleoside inhibitor 62 Dynepo 62 novel VDA molecule 62 Tasimelteon 62 Accolate 62 levosimendan 62 Aurograb 62 Tofacitinib 62 INS# [001] 62 albiglutide 62 INCB# [002] 62 Elvitegravir 62 selective modulator 62 XL# SAR# 62 isavuconazole 62 PDE# inhibitors 62 lenalidomide dexamethasone 62 irbesartan 62 beta interferons 62 Cimzia ® certolizumab pegol 62 RGB # 62 constipation predominant irritable bowel 62 LEP ETU 62 multicenter Phase II 62 Enzastaurin 62 EDEMA3 62 Zemplar Capsules 62 NATRECOR R 62 rilpivirine 62 lurasidone 62 AQ4N 62 rasagiline 62 CAELYX 62 personalized immunotherapy 62 non nucleoside HCV 62 Urocortin 2 62 APTIVUS r 62 adjuvant colon cancer 62 dirucotide MBP# 62 goserelin 62 tasimelteon 62 telaprevir VX 62 ketolide antibiotic 62 investigational protease inhibitor 62 oral FTY# 62 Hycamtin 62 Copegus ribavirin 62 EndoTAGTM 1 62 mitoxantrone plus 62 ruxolitinib 62 Temsirolimus 62 anidulafungin 62 oral mTOR inhibitor 62 Celgene Revlimid 62 Vilazodone 62 radezolid 62 TRIOLEX 62 Auxilium Pharma 62 REP# 62 lenalidomide Revlimid 62 Evoltra ® 62 MACUGEN 62 PREOS R 62 Vectibix panitumumab 62 TASKi3 62 CoFactor 62 rhThrombin 62 ITAX 62 Vfend 62 Phase IIa clinical trials 62 LE DT 62 FASLODEX 62 Phase III trials 62 IDX# 62 eritoran 62 blinded randomized placebo controlled 62 ribavirin Copegus 62 Fludara ® 62 PSMA ADC 62 Vidofludimus 62 tolvaptan 62 RAPTIVA 62 trastuzumab Herceptin R 62 Natalizumab 62 Orazol 62 aripiprazole Abilify 62 NASDAQ REGN 62 desvenlafaxine succinate 62 Randomized Phase 62 Entereg R 62 ambrisentan 62 Silodosin 62 ONTAK 62 Onrigin 62 MERLIN TIMI 62 Arixtra 62 ANTEGREN 62 OvaRex ® MAb 62 TREDAPTIVE 62 REYATAZ R 62 relapsing MS 62 Zybrestat 62 Asenapine 62 Dr. McHutchison 62 PANVAC VF 62 PARP inhibitor 62 Azilect ® 62 LEUKINE 62 dasatinib 62 MKC# MKC# PP 62 avosentan 62 Aceon 62 herpetic keratitis 62 ACTEMRA 62 PRX # 62 GlaxoSmithKline Tykerb 62 chronic idiopathic thrombocytopenic purpura 62 ILLUMINATE 62 TASKi2 62 Rasilez Tekturna 62 mGluR5 NAM 62 Cimzia certolizumab pegol 62 amrubicin 62 Elagolix 62 Certriad 62 Exelixis XL# 62 BAL# [002] 62 histone deacetylase HDAC inhibitor 62 Octreolin 62 Ixabepilone 62 SEBIVO 62 desmoteplase 62 Aclidinium 62 Arqule 62 telomerase therapeutic 62 midstage study 62 Pegasys ® 62 phase Ib clinical 62 lintuzumab SGN 62 capecitabine Xeloda 62 CCR9 antagonist 62 guanfacine extended release 62 adalimumab 62 Cariprazine 62 AMEVIVE 62 registrational 62 Vertex hepatitis C 62 basiliximab 62 ELACYT 62 investigational hepatitis C 61 Toremifene 61 pegylated interferon alpha 61 Proleukin 61 OMP #R# 61 Specifid 61 metastatic hormone refractory 61 Phase 1b clinical 61 Byetta exenatide 61 delivers fluocinolone acetonide FA 61 Entereg 61 Neupro R 61 epratuzumab 61 alkylating agent 61 tramiprosate 61 Cogane 61 Degludec 61 thymalfasin 61 Mycamine 61 PF # [001] 61 EVIZON 61 Capesaris 61 REBETOL combination therapy 61 calcineurin inhibitor 61 samalizumab 61 ACZ# 61 Phase Ib IIa 61 IRX 2 61 omecamtiv mecarbil 61 TroVax ® 61 Zometa zoledronic acid 61 CETP inhibitor 61 Androxal TM 61 Cladribine 61 epigenetic therapies 61 mepolizumab 61 gemifloxacin 61 Preclinical studies suggest 61 Febuxostat 61 oxaliplatin Eloxatin 61 BENLYSTA TM 61 Phase 2b trial 61 Romidepsin 61 aurora kinase 61 JAK1 61 Tygacil 61 long acting muscarinic 61 tecarfarin 61 aclidinium bromide 61 Potiga 61 INTEGRILIN ® 61 Azacitidine 61 relapsing multiple sclerosis 61 Telaprevir 61 Heplisav 61 Irinotecan 61 candesartan cilexetil 61 relapsed refractory multiple myeloma 61 SERMs 61 Recentin 61 PSN# [002] 61 VA# [002] 61 evaluating Actimmune 61 Sycrest 61 gepirone ER 61 palonosetron 61 Kuvan R 61 Ozarelix 61 AIM HIGH 61 renal toxicity 61 CRx 61 Saxagliptin 61 talabostat 61 BioNumerik 61 Ophena TM 61 ocular formulation 61 Nanobody 61 CINOD 61 nitazoxanide 61 BLP# Liposome Vaccine 61 metastatic RCC 61 cancer immunotherapies 61 E2F Decoy 61 Fulvestrant 61 ecallantide 61 Catena ® 61 Medidur FA 61 Zadaxin 61 Increlex R 61 Apixaban 61 taribavirin 61 tezampanel 61 ancrod 61 aplindore 61 APPRAISE 61 dalbavancin 61 photoprotective drug 61 LY# [002] 61 SCH # 61 WILEX 61 apixaban 61 iloperidone 61 torsemide ER 61 Pafuramidine 61 aprepitant 61 NATRECOR ® 61 picoplatin